Characterization of polymeric micelles for pulmonary delivery of beclomethasone dipropionate

Journal of Nanoscience and Nanotechnology

Volumn 6, Issue 9-10, 2006, Pages 3095-3101

  Gaber, Nazar Noureen ^a   Darwis, Yusrida ^a   Peh, Kok Khiang ^a   Tan, Yvonne Tze Fung ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Beclomethasone Dipropionate; Micelles; mPEG DSPE; Pulmonary Delivery

Indexed keywords

CORTICOSTEROIDS; HIGUCHI MODELS; PHOTON CORRELATION SPECTROSCOPY; PULMONARY DELIVERY;

DIFFERENTIAL SCANNING CALORIMETRY; DISPERSIONS; ENCAPSULATION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; MICELLES; PHARMACODYNAMICS; POLYMERS; PULMONARY DISEASES;

CONTROLLED DRUG DELIVERY;

BECLOMETASONE; DRUG CARRIER; NANOMATERIAL;

AEROSOL; ANIMAL; ARTICLE; CHEMISTRY; COLLOID; DIFFUSION; EVALUATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG; MATERIALS TESTING; METABOLISM; MICELLE; PARTICLE SIZE;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; BECLOMETHASONE; COLLOIDS; DIFFUSION; DRUG CARRIERS; HUMANS; LUNG; MATERIALS TESTING; MICELLES; NANOSTRUCTURES; PARTICLE SIZE;

EID: 33750051651     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2006.426     Document Type: Conference Paper

References (24)

1. S. Crowley, Pediatric Respiratory Reviews 4, 153 (2003).
2. C. Terzano, L. Allegra, F. Alhaique, C. Marianecci, and M. Carafa, Eur. J. Pharmaceut. Biopharmaceut. 59, 57 (2005).
3. Y. Darwis and I. W. Kellaway, Int. J. Pharm. 215, 113 (2001).
4. M. M. El-Baseir, M. A. Phipps, and I. W. Kellaway, Int. J. Pharm. 151, 145 (1997).
5. S. Hyvönen, L. Peltonen, M. Karjalainen, and J. Hirvonen, Int. J. Pharm. 295, 269 (2005).
6. M. C. Woodle, Adv. Drug Deliv. Rev. 32, 139 (1998).
7. M. C. Jones and J. C. Leroux, Eur. J. Pharmaceut. Biopharmaceut. 48, 101 (1999).
8. K. Kataoka, A. Harada, and Y. Nagasaki, Adv. Drug Deliv. Rev. 47, 113 (2001).
9. D. Marsh, R. Bartucci, and L. Sportelli, Biochimica et Biophysica Acta 1615, 33 (2003).
10. V. P. Torchilin, Adv. Drug Deliv. Rev. 57, 95 (2005).
11. C. Vermehren, K. Jørgensen, R. Schiffelers, and S. Frokjaer, Int. J. Pharm. 214, 93 (2001).
12. J. Davidsen, C. Vermehren, S. Frokjaer, O. G. Mouritsen, and K. Jørgensen, Int. J. Pharm. 214, 67 (2001).
13. N. A. Wiggins, Drug Dev. Ind. Pharm. 17, 1971 (1991).
14. H. Yamamoto, Y. Kuno, S. Sugimoto, H. Takeuchi, and Y. Kawashima, J. Control. Rel. 102, 373 (2004).
15. M. Yokoyama, A. Satoh, Y. Sakurai, T. Okano, Y. Matsumara, T. Kakizoe, and K. Kataoka, J. Control. Rel. 55, 219 (1998).
16. G. Kwon, M. Naito, M. Yokoyama, T. Okano, Y. Sakurai, and K. Kataoka, J. Control. Rel. 48, 195 (1997).
17. J. M. A. Abdulla, Y. Darwis, and Y. T. F. Tan, Proc. 14th Int. Symp. on Microencapsulation, Singapore, 4-6 (2003).
18. J. Wang, D. A. Mongayt, A. N. Lukyanov, T. S. Levchenko, and V. P. Torchilin, Int. J. Pharm. 272, 129 (2004).
19. J. X. Zhang, C. B. Hansen, T. M. Allen, A. Boey, and R. Boch, J. Control. Rel. 86, 323 (2003).
20. Y. Hu, X. Q. Jiang, Y. Ding, L. Y. Zhang, C. Z. Yang, J. F. Zhang, J. N. Chen, and Y. H. Yang, Biomaterials 24, 2395 (2003).
21. Q. Ye, J. Asherman, M. Stevenson, E. Brownson, and N. V. Katre, J. Control. Rel. 64, 155 (2000).
22. M. Sakagami, W. Kinoshita, K. Sakon, J. Sato, and Y. Makino, J. Control. Release 80, 207 (2002).
23. A. Vaghi, E. Berg, S. Liljedahl, and J. O. Svensson, Pulmonary Pharmacology and Therapeutics 18, 151 (2005).
24. M. Saari, M. T. Vidgren, M. O. Koskinen, V. M. H. Turjanmaa, and M. M. Nieminen, Int. J. Pharm. 181, 1 (1999).